New Technologies in pipe line
- Rec and PEGylated Staphylokinase (IPR secured)
- New Immuno-inhibitors and bioactives (leads)
- Biosensors for pesticides and Glyc-Hb
- New TB Vaccine (IPR secured)
- Clot-specific, protein-engineered streptokinase (clinical trials in progress).
- “Healing” clot buster/s with clot-specific and anti-thrombin properties (licensed to US company in Nov. 2010).
- Several other therapeutic molecules are also in the pipe-line/anvil (Oral thrombolytics, Human Abs, longer-lasing EPO etc).
This site is best viewed in Mozilla Firefox, Internet Explorer 8 and above at screen resolution of 1024 x 768 and above.